Your browser doesn't support javascript.
loading
Anesthetic management for large vessel occlusion acute ischemic stroke with tandem lesions.
Farooqui, Mudassir; Galecio-Castillo, Milagros; Hassan, Ameer E; Divani, Afshin A; Jumaa, Mouhammad; Ribo, Marc; Petersen, Nils H; Abraham, Michael G; Fifi, Johanna T; Guerrero, Waldo R; Malik, Amer; Siegler, James E; Nguyen, Thanh N; Sheth, Sunil A; Yoo, Albert J; Linares, Guillermo; Janjua, Nazli; Quispe-Orozco, Darko; Tekle, Wondwossen G; Sabbagh, Sara Y; Zaidi, Syed F; Olive Gadea, Marta; Prasad, Ayush; Qureshi, Abid; De Leacy, Reade Andrew; Abdalkader, Mohamad; Salazar-Marioni, Sergio; Soomro, Jazba; Gordon, Weston; Turabova, Charoskhon; Rodriguez-Calienes, Aaron; Vivanco-Suarez, Juan; Mokin, Maxim; Yavagal, Dileep R; Jovin, Tudor G; Ortega-Gutierrez, Santiago.
Affiliation
  • Farooqui M; Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Galecio-Castillo M; Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Hassan AE; Department of Neurology, University of Texas Rio Grande Valley, Harlingen, Texas, USA.
  • Divani AA; Neurology, University of New Mexico Health System, Albuquerque, New Mexico, USA.
  • Jumaa M; Neurology, Promedica Toledo Hospital, Toledo, Ohio, USA.
  • Ribo M; Stroke Unit, Neurology, Hospital Vall d'Hebron, Barcelona, Spain.
  • Petersen NH; Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Abraham MG; Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Fifi JT; Neurology and Radiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Guerrero WR; Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Malik A; Neurosurgery, University of South Florida, Tampa, Florida, USA.
  • Siegler JE; Neurology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Nguyen TN; Cooper Neurological Institute, Cooper University Health Care, Camden, New Jersey, USA.
  • Sheth SA; Neurology, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Yoo AJ; Neurology, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Linares G; Neurointervention, Texas Stroke Institute, Plano, Texas, USA.
  • Janjua N; Neurology, School of Medicine Saint Louis University, Saint Louis, Missouri, USA.
  • Quispe-Orozco D; Neurology, Pomona Valley Hospital Medical Center, Pomona, California, USA.
  • Tekle WG; Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Sabbagh SY; Department of Neurology, Valley Baptist Medical Center - Harlingen, Harlingen, Texas, USA.
  • Zaidi SF; Neurology, University of New Mexico Health System, Albuquerque, New Mexico, USA.
  • Olive Gadea M; Neurology, University of Toledo Health Science Campus, Toledo, Ohio, USA.
  • Prasad A; Neurology, Hospital Vall d'Hebron, Barcelona, Barcelona, Spain.
  • Qureshi A; Yale University School of Medicine, New Haven, Connecticut, USA.
  • De Leacy RA; Neurology and Radiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Abdalkader M; Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Salazar-Marioni S; Radiology, Boston Medical Center, Boston, Massachusetts, USA.
  • Soomro J; Neurology, University of Texas McGovern Medical School, Houston, Texas, USA.
  • Gordon W; Texas Stroke Institute, Plano, Texas, USA.
  • Turabova C; Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Rodriguez-Calienes A; Neurology, Pomona Valley Hospital Medical Center, Pomona, California, USA.
  • Vivanco-Suarez J; The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Mokin M; Grupo de Investigacion Neurociencia, Efectividad Clinica y Salud Publica, Universidad Cientifica del Sur Facultad de Ciencias de la Salud, Lima, Peru.
  • Yavagal DR; Neurology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
  • Jovin TG; Neurosurgery, University of South Florida College of Medicine, Tampa, Florida, USA.
  • Ortega-Gutierrez S; Neurology and Neurosurgery, University of Miami, Miami, Florida, USA.
J Neurointerv Surg ; 2024 Mar 01.
Article in En | MEDLINE | ID: mdl-38429099
ABSTRACT

BACKGROUND:

Endovascular therapy (EVT) stands as an established and effective intervention for acute ischemic stroke in patients harboring tandem lesions (TLs). However, the optimal anesthetic strategy for EVT in TL patients remains unclear. This study aims to evaluate the impact of distinct anesthetic techniques on outcomes in acute ischemic stroke patients presenting with TLs.

METHODS:

Patient-level data, encompassing cases from 16 diverse centers, were aggregated for individuals with anterior circulation TLs treated between January 2015 and December 2020. A stratification based on anesthetic technique was conducted to distinguish between general anesthesia (GA) and procedural sedation (PS). Multivariable logistic regression models were built to discern the association between anesthetic approach and outcomes, including the favorable functional outcome defined as 90-day modified Rankin Score (mRS) of 0-2, ordinal shift in mRS, symptomatic intracranial hemorrhage (sICH), any hemorrhage, successful recanalization (modified Thrombolysis In Cerebral Infarction (mTICI) score ≥2b), excellent recanalization (mTICI 3), first pass effect (FPE), early neurological improvement (ENI), door-to-groin and recanalization times, intrahospital mortality, and 90-day mortality.

RESULTS:

Among 691 patients from 16 centers, 595 patients (GA 38.7%, PS 61.3%) were included in the final analysis. There were no significant differences noted in the door-to-groin time (80 (46-117.5) mins vs 54 (21-100), P=0.607) and groin to recanalization time (59 (39.5-85.5) mins vs 54 (38-81), P=0.836) among the groups. The odds of a favorable functional outcome (36.6% vs 52.6%; adjusted OR (aOR) 0.56, 95% CI 0.38 to 0.84, P=0.005) and a favorable shift in the 90-day mRS (aOR 0.71, 95% CI 0.51 to 0.99, P=0.041) were lower in the GA group. No differences were noted for sICH (3.9% vs 4.7%, P=0.38), successful recanalization (89.1% vs 86.5%, P=0.13), excellent recanalization (48.5% vs 50.3%, P=0.462), FPE (53.6% vs 63.4%, P=0.05), ENI (38.9% vs 38.8%, P=0.138), and 90-day mortality (20.3% vs 16.3%, P=0.525). An interaction was noted for favorable functional outcome between the type of anesthesia and the baseline Alberta Stroke Program Early CT Score (ASPECTS) (P=0.033), degree of internal carotid artery (ICA) stenosis (P<0.001), and ICA stenting (P<0.001), and intraparenchymal hematoma between the type of anesthesia and intravenous thrombolysis (P=0.019). In a subgroup analysis, PS showed better functional outcomes in patients with age ≤70 years, National Institutes of Health Stroke Scale (NIHSS) score <15, and acute ICA stenting.

CONCLUSIONS:

Our findings suggest that the preference for PS not only aligns with comparable procedural safety but is also associated with superior functional outcomes. These results prompt a re-evaluation of current anesthesia practices in EVT, urging clinicians to consider patient-specific characteristics when determining the optimal anesthetic strategy for this patient population.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurointerv Surg Year: 2024 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Neurointerv Surg Year: 2024 Document type: Article Affiliation country: United States